Tesamorelin GHRH groeihormoon vrijgevende factor analoog

Tesamorelin GHRH Growth Hormone Releasing Factor Analogue for sale

What is Tesamorelin ?

Tesamorelin (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. The drug is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.

productnaam: Tesamorelin
CAS: 218949-48-5
Moleculaire formule: C221H366N72O67S.xC2H4O (x ≈ 7)
Molecuulgewicht: 5135.9

Tesamorelin can not only adjust the body growth hormone secretion to normal level, but also increased visceral adipose tissue (VAT) decreased, and can improve dyslipidemia and quality of life, maintain glucose homeostasis. The drug was approved by the FDA in November 2010 for marketing of HIV-associated lipodystrophy syndrome. It is For the treatment of abdominal hyperlipidemia in HIV-infected patients with lipodystrophy, but not recommended for weight loss.

Peptide-OEM: Wij leveren al jaren peptidehormoon, Tesamorelin GHRH Growth Hormone Releasing Factor Analogue for sale. we kunnen aangepaste productie doen voor sommige peptiden in 0,1 mg,0.5mg,1mg,2mg,5mg,10mg/flacon als u dat nodig heeft, met elke kleur filp-off caps.

Peptidepoedervorm en peptidecombinatie met meerdere ingrediënten is beschikbaar. (aangepaste productie is alleen voor de hoeveelheid actief ingrediëntpeptide hierboven 1 gram )